DVA Quote, Financials, Valuation and Earnings

Encompass Health Corp. has a net margin of 7.02% compared to DaVita, Inc.'s net margin of 11.82%. DaVita, Inc.'s return on equity of 61.87% beat Encompass Health Corp.'s return on equity of 24.34%.

DaVita, Inc. has a consensus price target of $144.50, signalling upside risk potential of 25.96%. On the other hand Encompass Health Corp. has an analysts' consensus of $140.33 which suggests that it could grow by 30.87%. Given that Encompass Health Corp. has higher upside potential than DaVita, Inc., analysts believe Encompass Health Corp. is more attractive than DaVita, Inc..

DaVita, Inc. has a beta of 0.996, which suggesting that the stock is 0.439% less volatile than S&P 500. In comparison Encompass Health Corp. has a beta of 0.746, suggesting its less volatile than the S&P 500 by 25.418%.

DaVita, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Encompass Health Corp. offers a yield of 0.65% to investors and pays a quarterly dividend of $0.19 per share. DaVita, Inc. pays -- of its earnings as a dividend. Encompass Health Corp. pays out 14.35% of its earnings as a dividend. Encompass Health Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

DaVita, Inc. quarterly revenues are $3.4B, which are larger than Encompass Health Corp. quarterly revenues of $1.5B. DaVita, Inc.'s net income of $240.2M is higher than Encompass Health Corp.'s net income of $174.7M. Notably, DaVita, Inc.'s price-to-earnings ratio is 11.81x while Encompass Health Corp.'s PE ratio is 20.27x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for DaVita, Inc. is 0.68x versus 1.89x for Encompass Health Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Healthcare Services Group, Inc. has a net margin of 7.02% compared to DaVita, Inc.'s net margin of 9.25%. DaVita, Inc.'s return on equity of 61.87% beat Healthcare Services Group, Inc.'s return on equity of 8.02%.

DaVita, Inc. has a consensus price target of $144.50, signalling upside risk potential of 25.96%. On the other hand Healthcare Services Group, Inc. has an analysts' consensus of $21.50 which suggests that it could grow by 9.81%. Given that DaVita, Inc. has higher upside potential than Healthcare Services Group, Inc., analysts believe DaVita, Inc. is more attractive than Healthcare Services Group, Inc..

DaVita, Inc. has a beta of 0.996, which suggesting that the stock is 0.439% less volatile than S&P 500. In comparison Healthcare Services Group, Inc. has a beta of 0.752, suggesting its less volatile than the S&P 500 by 24.779%.

DaVita, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Healthcare Services Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. DaVita, Inc. pays -- of its earnings as a dividend. Healthcare Services Group, Inc. pays out -- of its earnings as a dividend.

DaVita, Inc. quarterly revenues are $3.4B, which are larger than Healthcare Services Group, Inc. quarterly revenues of $464.3M. DaVita, Inc.'s net income of $240.2M is higher than Healthcare Services Group, Inc.'s net income of $43M. Notably, DaVita, Inc.'s price-to-earnings ratio is 11.81x while Healthcare Services Group, Inc.'s PE ratio is 36.23x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for DaVita, Inc. is 0.68x versus 0.80x for Healthcare Services Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Surgery Partners, Inc. has a net margin of 7.02% compared to DaVita, Inc.'s net margin of 3.08%. DaVita, Inc.'s return on equity of 61.87% beat Surgery Partners, Inc.'s return on equity of 0.65%.

DaVita, Inc. has a consensus price target of $144.50, signalling upside risk potential of 25.96%. On the other hand Surgery Partners, Inc. has an analysts' consensus of $25.45 which suggests that it could grow by 63.91%. Given that Surgery Partners, Inc. has higher upside potential than DaVita, Inc., analysts believe Surgery Partners, Inc. is more attractive than DaVita, Inc..

DaVita, Inc. has a beta of 0.996, which suggesting that the stock is 0.439% less volatile than S&P 500. In comparison Surgery Partners, Inc. has a beta of 1.932, suggesting its more volatile than the S&P 500 by 93.198%.

DaVita, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Surgery Partners, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. DaVita, Inc. pays -- of its earnings as a dividend. Surgery Partners, Inc. pays out -- of its earnings as a dividend.

DaVita, Inc. quarterly revenues are $3.4B, which are larger than Surgery Partners, Inc. quarterly revenues of $821.5M. DaVita, Inc.'s net income of $240.2M is higher than Surgery Partners, Inc.'s net income of $25.3M. Notably, DaVita, Inc.'s price-to-earnings ratio is 11.81x while Surgery Partners, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for DaVita, Inc. is 0.68x versus 0.60x for Surgery Partners, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

SRx Health Solutions, Inc. has a net margin of 7.02% compared to DaVita, Inc.'s net margin of -13.47%. DaVita, Inc.'s return on equity of 61.87% beat SRx Health Solutions, Inc.'s return on equity of --.

DaVita, Inc. has a consensus price target of $144.50, signalling upside risk potential of 25.96%. On the other hand SRx Health Solutions, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that DaVita, Inc. has higher upside potential than SRx Health Solutions, Inc., analysts believe DaVita, Inc. is more attractive than SRx Health Solutions, Inc..

DaVita, Inc. has a beta of 0.996, which suggesting that the stock is 0.439% less volatile than S&P 500. In comparison SRx Health Solutions, Inc. has a beta of 0.929, suggesting its less volatile than the S&P 500 by 7.069%.

DaVita, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SRx Health Solutions, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. DaVita, Inc. pays -- of its earnings as a dividend. SRx Health Solutions, Inc. pays out -- of its earnings as a dividend.

DaVita, Inc. quarterly revenues are $3.4B, which are larger than SRx Health Solutions, Inc. quarterly revenues of $7.2M. DaVita, Inc.'s net income of $240.2M is higher than SRx Health Solutions, Inc.'s net income of -$964K. Notably, DaVita, Inc.'s price-to-earnings ratio is 11.81x while SRx Health Solutions, Inc.'s PE ratio is 0.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for DaVita, Inc. is 0.68x versus 0.04x for SRx Health Solutions, Inc.. Usually stocks with elevated PS ratios are considered overvalued.